Olean man sentenced 3-9 years for hit-and-run death
Breaking News
KELLEN M. QUIGLEY kquigley@oleantimesherald.com 
August 27, 2025
OLEAN — An Olean man was sentenced Monday in Cattaraugus County Court to three to nine years in state prison for a 2023 hit-and-run collision on Senec...
Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)
Press Releases
Johnson & Johnson  
April 30, 2025

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)

First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older

avatar profile Olean Times Herald

Olean Times Herald


Local & Social